《胃癌預(yù)警和早期診斷系統(tǒng)(英文版)》系“轉(zhuǎn)化醫(yī)學(xué)出版工程:技術(shù)系列”之一,是關(guān)于納米技術(shù)應(yīng)用于胃癌早期檢測系統(tǒng)的研究,主要內(nèi)容包括胃癌標(biāo)志物的篩選與鑒定;胃癌標(biāo)志物超敏感特異性檢測方法與診療器械研發(fā);納米粒子的制備與胃癌靶向成像與治療一體化的多功能納米探針的研制與應(yīng)用;胃癌標(biāo)志物快速檢測傳感器器件的研發(fā)與臨床轉(zhuǎn)化;胃癌循環(huán)血癌細(xì)胞的捕獲與定量設(shè)備的研發(fā);胃癌十細(xì)胞靶向成像與治療的進(jìn)展;胃痛細(xì)胞免疫治療的進(jìn)展;胃癌納米探針的安全性評價(jià)與臨床轉(zhuǎn)化;原位胃癌分子分型的研究現(xiàn)狀與指導(dǎo)靶向治療藥物的篩選;胃痛預(yù)警數(shù)據(jù)庫和影像數(shù)據(jù)庫的進(jìn)展;胃癌預(yù)警與早期診斷系統(tǒng)臨床轉(zhuǎn)化的技術(shù)前景。
《胃癌預(yù)警和早期診斷系統(tǒng)(英文版)》是一本多學(xué)科交義研究的結(jié)果總結(jié),同時(shí)也對相關(guān)的研究進(jìn)展進(jìn)行了綜述,對研究生、從事胃癌研究的人員以及臨床醫(yī)師都具有極高的參考價(jià)值與指導(dǎo)意義。
Over the years, a chasm between biomedical researchers and the patients who may benefit from their discoveries has been opened. On one hand, millions of patients with diseases such as cancer are anxiously waiting for new remedies to save their lives. On the other hand, many exciting basic science discoveries do not have opportunities to find practical applications. Recently emerging translational medicine aims to tie basic research to clinical results and optimize both patient care and preventive measures.
Translational medicine converts promising laboratory discoveries into clinical applications and elucidates clinical questions with the use of bench work, aiming to facilitate prediction, prevention, diagnosis, and treatment of diseases. With the ultimate goal to develop more effective preventive/therapeutic approaches and improve clinical outcomes and health levels, translational medicine is therefore a people (patients and the general population as a whole)-oriented medical practice.
The past three decades have witnessed tremendous advances in China in the development of living conditions, food and nutrition, and the health care system. However, while the economy grows and society rapidly transforms, the health care system faces multiple problems. China bears a complex disease spectrum: On one hand, communicable diseases frequently seen in developing countries remain a heavy burden; on the other hand, chronic diseases commonly found in developed countries are also the leading causes of death and disability in China. The situation shows that the health care system in China is facing great challenges, and a state effort is needed to meet these challenges. Therefore China is deepening its reform to improve its people's welfare. The development of translational medicine will accelerate disease control and finding solutions for health problems.
Translational medicine is a multidisciplinary program that integrates research from the medical sciences, basic sciences, and social sciences, with the aim of optimizing patient care and preventive measures that may extend beyond health care services. Therefore, close collaboration in an international scale among all the parties is essential to the development of translational medicine.
To enhance the aforementioned international collaboration as well as to provide a forum for communication and cross-fertilization among basic, translational, and clinical research practitioners, we launch the book series "Translational Medicine Research". It features original and observational investigations in the broad fields of laboratory, clinical, and public health research, aiming to provide practical upto-date information in significant research from all subspecialr.ies of medicine and to broaden t.he readers' vision and horizon from bench to bed and bed to bench.
In close collaboration with National Infrastructures for Translational Medicine (Shanghai), the book series "Translational Medicine Research" serves as a stateof-the-art resource Of physicians and translational medical researchers alike who are int.erested in the rapidly evolving field of translational medicine. As the Editor- in-Chief, I welcome all the researchers in related areas to report the latest bench- to-bedside researches in this series, so that the series can promote human health by accelerating the knowledge dissemination in global community.
1 Background of Gastric Cancer Prewarning and Early Diagnosis System
Daxiang Cui
2 Human Serum Protein Markers for Gastric Cancer Detection
Hualin Fu and Daxiang Cui
3 Screening and Detection of Gastric Cancer Circulating MicroRNA Biomarkers
Zhang Jingpu and Daxiang Cui
4 Screening and Identification of Biomarkers from Gastric Cancer Saliva Metabolites
Shangli Cheng and Daxaing Cui
5 Metabolic Profiles and High-Accuracy Diagnosis Model Based on Plasma Metabolomics of Gastric Cancer Patients
Cheng Shangli and Daxiang Cui
6 Identification of Volatile Organic Compound Biomarkers Associated with Gastric Cancer Cells and Their Ultrasensitive Electrochemical Detection
Yixia Zhang and Daxiang Cui
7 A Breath Analysis Based on SERS Sensor to Distinguish Patients with Early and Advanced Stages of Gastric Cancer from Healthy People
Yunsheng Chen and Daxiang Cui
8 The Application of Immunochromatographic Analysis in Early Detection of Gastric Cancer
Kan Wang and Daxiang Cui
9 Applications of Magnetic Nanoparticle-Based High-Throughput Single-Nucleotide Polymorphism Genotyping Platforms in Gastric Cancer Research
Song Li, Hongna Liu, and Nongyue He
10 Single-Cell Manipulation Technology for Cancer Research
Shujing Lin, Di Chen, and Yao Xie
11 Multifunctional Nanoprobes for Theranostics of Gastric Cancer.
Daxiang Cui
12 Upconversion Nanoparticles for Gastric Cancer Targeted Imaging and Therapy
Yuming Yang and Daxiang Cui
13 Stem Cells and Gastric Cancer
Meng Yang and Daxiang Cui
14 Safety Assessment of Nanoprobes
Yanlei Liu, Yuxia Wang, and Daxiang Cui
15 Gastric Cancer Prewarning Database and Bioinformatics Analysis
Cheng Shangli and Daxiang Cui